Strata Critical Medical, Stock Performance
| SRTA Stock | 4.87 0.11 2.21% |
The entity has a beta of 3.09, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Strata Critical will likely underperform. Strata Critical Medical, right now has a risk of 4.06%. Please validate Strata Critical kurtosis, as well as the relationship between the day median price and period momentum indicator , to decide if Strata Critical will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Strata Critical Medical, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Strata Critical is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (2.21) | Five Day Return (5.80) | Year To Date Return 14.59 | Ten Year Return (50.05) | All Time Return (50.05) |
1 | Strength Seen in Teladoc Can Its 6.3 percent Jump Turn into More Strength | 10/06/2025 |
2 | Disposition of 55555 shares by Tomkiel Melissa M. of SRTA at 0.18 subject to Rule 16b-3 | 10/10/2025 |
3 | Disposition of 55556 shares by Tomkiel Melissa M. of SRTA at 0.18 subject to Rule 16b-3 | 10/22/2025 |
4 | Acquisition by William Heyburn of 181072 shares of SRTA subject to Rule 16b-3 | 10/31/2025 |
5 | Disposition of 100133 shares by William Heyburn of SRTA at 5.03 subject to Rule 16b-3 | 11/03/2025 |
6 | AMN Healthcare Services Beats Q3 Earnings and Revenue Estimates | 11/07/2025 |
7 | Blade Air Mobility GAAP EPS of -0.12 misses by 0.10, revenue of 49.29M beats by 5.54M | 11/10/2025 |
8 | Disposition of 11000 shares by Love Reginald of Strata Critical at 4.3122 subject to Rule 16b-3 | 11/19/2025 |
9 | Disposition of 11000 shares by Love Reginald of Strata Critical at 4.37 subject to Rule 16b-3 | 11/20/2025 |
10 | Acquisition by Lauck Andrew of 5000 shares of Strata Critical at 4.365 subject to Rule 16b-3 | 12/05/2025 |
11 | Acquisition by William Heyburn of 17000 shares of Strata Critical at 4.4732 subject to Rule 16b-3 | 12/09/2025 |
12 | Disposition of 3716 shares by Amir Cohen of Strata Critical at 4.38 subject to Rule 16b-3 | 12/10/2025 |
13 | When Will Strata Critical Medical, Inc. Breakeven | 12/12/2025 |
| Begin Period Cash Flow | 29 M | |
| Total Cashflows From Investing Activities | -1 M |
Strata Critical Relative Risk vs. Return Landscape
If you would invest 510.00 in Strata Critical Medical, on September 29, 2025 and sell it today you would lose (23.00) from holding Strata Critical Medical, or give up 4.51% of portfolio value over 90 days. Strata Critical Medical, is currently generating 0.0071% in daily expected returns and assumes 4.0643% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Strata, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Strata Critical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Strata Critical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Strata Critical Medical,, and traders can use it to determine the average amount a Strata Critical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0017
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SRTA |
Based on monthly moving average Strata Critical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Strata Critical by adding Strata Critical to a well-diversified portfolio.
Strata Critical Fundamentals Growth
Strata Stock prices reflect investors' perceptions of the future prospects and financial health of Strata Critical, and Strata Critical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Strata Stock performance.
| Return On Equity | -0.24 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.55) % | ||||
| Operating Margin | (0.43) % | ||||
| Current Valuation | 272.55 M | ||||
| Shares Outstanding | 85.13 M | ||||
| Price To Book | 1.69 X | ||||
| Price To Sales | 6.21 X | ||||
| Revenue | 248.69 M | ||||
| Gross Profit | 13.17 M | ||||
| EBITDA | (27.96 M) | ||||
| Net Income | (27.31 M) | ||||
| Total Debt | 9.32 M | ||||
| Book Value Per Share | 4.18 X | ||||
| Cash Flow From Operations | (2.52 M) | ||||
| Earnings Per Share | (0.24) X | ||||
| Market Capitalization | 417.35 M | ||||
| Total Asset | 256.68 M | ||||
| Retained Earnings | (186.9 M) | ||||
| Working Capital | 138.02 M | ||||
About Strata Critical Performance
By analyzing Strata Critical's fundamental ratios, stakeholders can gain valuable insights into Strata Critical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Strata Critical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Strata Critical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 2.99 | 3.54 | |
| Return On Tangible Assets | (0.14) | (0.14) | |
| Return On Capital Employed | (0.15) | (0.15) | |
| Return On Assets | (0.11) | (0.11) | |
| Return On Equity | (0.12) | (0.13) |
Things to note about Strata Critical Medical, performance evaluation
Checking the ongoing alerts about Strata Critical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Strata Critical Medical, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Strata Critical had very high historical volatility over the last 90 days | |
| Strata Critical Medical, was previously known as BLDE Old and was traded on NASDAQ Exchange under the symbol BLDE. | |
| The company reported the previous year's revenue of 248.69 M. Net Loss for the year was (27.31 M) with profit before overhead, payroll, taxes, and interest of 13.17 M. | |
| Strata Critical generates negative cash flow from operations | |
| Strata Critical has a frail financial position based on the latest SEC disclosures | |
| About 69.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: When Will Strata Critical Medical, Inc. Breakeven |
- Analyzing Strata Critical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Strata Critical's stock is overvalued or undervalued compared to its peers.
- Examining Strata Critical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Strata Critical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Strata Critical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Strata Critical's stock. These opinions can provide insight into Strata Critical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Strata Stock analysis
When running Strata Critical's price analysis, check to measure Strata Critical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Strata Critical is operating at the current time. Most of Strata Critical's value examination focuses on studying past and present price action to predict the probability of Strata Critical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Strata Critical's price. Additionally, you may evaluate how the addition of Strata Critical to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |